Our Team Sample Clauses

Our Team. 4.1 We will use reasonable efforts to ensure that our Representatives named in the Letter are available to provide the Services. However, if we need to, we may replace or reassign any Representative at any time on reasonable notice to you.
AutoNDA by SimpleDocs
Our Team. Given the multi-dimensional nature of the COVID-19 crisis and the nature of the tasks included in the Request for Cost Proposal, we have outlined an approach that combines ongoing access to McKinsey’s leadership team, subject matter experts, and as-needed surges of research and analytic support throughout the entire period of performance – plus a four-week surge of a dedicated team. This team structure will allow the work to ramp-up as requested, surge with focused support to drive quick progress on the most time-intensive deliverables, and then provide ongoing counsel, analysis, and refinement over the longer period. Our leadership team throughout the period of performance will include Xxxxx Xxx Xxxxxx (Senior Partner), Xxxxx Xxxxx (Senior Partner), Xxxx Xxxxxx (Partner), Xxxxx Xxxxxx-Xxx (Partner), Xxxxxxx Xxxxx (Partner), Xxxx Xxxxxxxxxx (Senior Expert), Xxxx Xxxxxx (Associate Partner), XX Xxxxxx (Engagement Manager), and Xxxxxx Xxxxxxxxxxx (Engagement Manager). We will draw in additional expertise from leading McKinsey experts in public health and healthcare, fiscal/tax assessment, economic development, and crisis and disaster response, and bring in analytic support from our research and insights team as needed. As part of our global and US efforts supporting institutions on the COVID-19 crisis, we have stood up a central COVID-19 Response team for the US public sector in addition to a Global Public Xxxxxx XXXXX- 00 Response team. These central teams ensure best practices and learnings gathered in supporting COVID-19 responses efforts globally can help inform New Jersey’s response. We also have dedicated COVID-19 response teams by sector (e.g., banking, real estate, pharmaceuticals, retail, logistics) who can give NJEDA and the State unparalleled insight into the concerns, likely responses, and industry dynamics as the crisis evolves. Our four-week surge of support will include a full-time Engagement Manager plus three dedicated Associates and/or Analysts. See Appendix A for additional details on our team and proposed staff.
Our Team. 4.1 Each of us agrees that, during the term of this Agreement and for a period of twelve months after it ends, neither of us will directly or indirectly employ or contract any Representative of the other who is involved with the Services and Deliverables. A fee of $40,000 will be payable to the other party in the event that this term is breached.
Our Team. Our Laboratory Team consists of experienced scientists, molecular technologists, data analysts and public health professionals and is led by X. Xxxxxx Xxxx, M.D., an experienced molecular diagnostic pathologist and NIH-funded investigator.
Our Team. At etc there is a strong desire to establish a sense of community with everyone involved throughout all stages of a project. We keep channels of communication open — projects seem to move along more rapidly when everyone involved knows what to expect. VALLEY VIEW HOUSES JOHN DAY, OR CANYON CITY COMMUNITY HALL BANK OF EASTERN OREGON PARKING LOT XXXX DAY FIRE HALL XXXXX CITY ARMORY Select Xxxx Day Office Projects Subdivision Development Canyon Mountain Heights Subdivision– Canyon City, OR Little Canyon Mountain Height Subdivision – Canyon City, OR Xxxxxx Fork Estates Subdivision – Long Creek, OR Xxxxxxx Butte Subdivision – Prineville, OR Rivers Edge Subdivision – Spray, OR Cracker Creek Subdivision – Sumpter, OR Indian Rock Subdivision Phase I & II – Prineville, OR Stone Ridge Subdivision – Xxxxxxxx, ID Xxxxxxxx Minor Partion Improvements – John Day, OR Lundy Minor Partion Improvements – Canyon City, OR Xxxxx Xxxxx Partion Improvements – Canyon City, OR Xxxxxxxxx Minor Partion Improvements – John Day, OR Xxxx Xxxxx Partion Land Development – Condon, OR Low Income & Assisted Living Canyon East Farmworkers Housing – Madras, OR Strawberry Apartment Site Rehab – Prairie City, OR Valley View Addition – Xxxx Day, OR Step Foreward Homes Site Design/Planning – John Day, OR Multi-Family Site Design Crest Butte Apartments Site Design – Bend, OR Castle Rock Apartments – Xxxxxxxx, OR Industrial/Commercial Site Design Grant County Ag Facility at Fairgrounds – John Day, OR JD Rents Site Design – John Day, OR Sunriver Plaza Parking, Access, and Drainage Rebuild – Sunriver, OR Bank of Eastern Oregon Parking Lot Rebuild – John Day, OR 1188 Brew Pub Frontage Improvements – John Day, OR Valley View Addition – John Day, OR Public Project Site Design Xxxxx City USFS Work Center Site Improvements – Xxxxx City, OR Vale Senor Center Site Improvements – Vale, OR Unity USFS Site Improvements – Unity, OR Columbia River Health Clinic – Boardman, OR Xxxxx City Armory Parking Lot Improvements – Xxxxx City, OR Xxxxx Butte Emergency Communications Tower – Grant County, OR Grant County Road Department Storage Shed – Xxxx Day, OR Head Start Facility – Umatilla, OR Warm Springs Fire Management Facility – Warm Springs, OR Community Presbyterian Church Site Improvements – Redmond, OR Xxxx Day Fire Hall – John Day, OR XXXXX CREEK CULVERT CANYON CITY SPRING BOX CONSTRUCTION
Our Team. As part of this project we would draw expertise from across the organisation, a profile of senior staff who would be involved in this programme is provided below. These will be supplemented by development, analytical and production staff as required. Dr Xxxxxxx Xxxxx (Chief Executive Officer) Xxxxxxx has a degree in Pharmacy from Queen’s University, Belfast and an MSc in Pharmaceutical Sciences from the University of Sunderland. He has over 20 years of product development experience (R&D and commercial) covering a wide range of dosage forms and delivery systems. He previously worked for Sterling Winthrop, Sanofi, Chiroscience, Celltech and UCB. During the course of his career he has been involved in the development and commercialisation of a number of successful drug products, drug delivery technologies and patent filings. Immediately prior to joining Encap Drug Delivery he was Director of Product Technology Development for UCB Celltech. Dr Xxxx Xxxxxx (R&D Director) Xxxx has over 11 years experience in the Pharmaceutical and Biopharmaceutical Industry and immediately prior to joining Encap Drug Delivery was Director of Pharmaceutics at Aptuit (formerly Quintiles). She has a BSc (Hons) in Applied Biochemistry and a PhD from the University of Paisley, Scotland. Xxxx joined Quintiles in 2001 as a Senior Formulation Scientist and rapidly progressed through supervisory and Management roles at the company. Xxxx has an outstanding track record in drug product development, with particular emphasis on oral dosage forms. Xxxxxxx Xxxxxxxxx (Chief Scientific Officer) After a period within academic research, Massoud joined the pharmaceutical industry and became involved in product development, holding senior positions in a variety of areas including clinical trials manufacture (Phase I and II) and Quality Assurance. He joined Encap in 1997 and was appointed as Chief Scientific Officer in 2005. Massoud has over 20 years experience in the pharmaceutical industry and is author/co-author of over 20 scientific papers and over 10 patents. Massoud gained his BSc in Chemistry from Tehran University and holds an MSc in Chemistry from Salford University. [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Xx Xxx Xxxxx (Head of Process Development) Vic has a BSc (Hons) in Chemistry from X...
Our Team. The core team of recruitment professionals assigned to this project possess relevant experience, including many years of public service, consulting expertise and executive-search experience. Xxxxx Xxxxxxx will serve as project director, providing strategic direction to the project manager, setting context, and providing useful insights to the County. Xxxxxx Xxxxxxxx of Xxxxx Xxxxx will serve as the project manager and lead recruiter, using both his recruiting and subject-matter expertise in human resources to help clarify the County’s priorities and uncover and evaluate candidates. The proposed team also includes Xxxxxxxxx XxXxxx, whose past work with the County will assist in understanding the context for the search, and our recruitment support team who will conduct thorough research into prospects, support production of the recruitment brochure and ad postings, and ensure timely response to candidates. In addition, we will use the knowledge and networks of our team of special advisors to extend the reach and screening capabilities of this search. The qualifications of our team members are summarized below. Xxxxx Xxxxxxx, Vice President Xxxxx is an experienced local government professional with over 25 years of experience leading organizational development, strategic and work force planning, executive recruitment, performance management, teambuilding, and facilitation engagements for public sector agencies. Early in her career, Xxxxx worked a professional executive recruitment firm, where she led candidate research efforts. Since then, she worked for the County of San Mateo and then in 2006 joined Management Partners. She is active in professional associations, including as past president of the Municipal Management Association of Northern California, founder of the Women’s Leadership Summit, and serves as the chair of the Cal-ICMA Talent Initiative. She is certified in a variety of professional assessment instruments, including the Xxxxx-Xxxxxx Type Indicator, DiSC, and CPI260 coaching assessment and leads our executive search practice. She has conducted executive recruitments for large and small public sector agencies across the west. Xxxxxx Xxxxxxxx, Ph.D., Director, Xxxxx Xxxxx Xxxxxx has more than 20 years of collective experience in human resources and organizational development at various levels and across various disciplines including, state and municipal government, community and educational institutions. His areas of expertise include human deve...
AutoNDA by SimpleDocs
Our Team. Competitive gymnastics is fun work at North Shore Gymnastics. We feel that gymnastics should be fun, yet constructive, thereby making practice enjoyable for everyone involved. Let’s face it, practice is 2-3 hours long, at least three time a week year round. The children and coaches spend a lot of time together, so if the work at hand is fun, is it work? The team is expected to train for the entire practice session including conditioning. We promote friendly competition in the gym. As with our staff, demeaning or condescending behavior from our gymnasts will not be tolerated and will be corrected immediately. We train as a team, compete as a team and have fun as a team.

Related to Our Team

  • Project Team To accomplish Owner’s objectives, Owner intends to employ a team concept in connection with the construction of the Project. The basic roles and general responsibilities of team members are set forth in general terms below but are more fully set forth in the Design Professional Contract with respect to the Design Professional, in the Program Management Agreement with any Program Manager, and in this Contract with respect to the Contractor.

  • Management Team Subject to any approval or consulting rights of the --------------- Joint Operations Committee, Manager shall engage or designate one or more individuals experienced in dental group management and direction, including, but not limited to, an administrator, who will be responsible for the overall administration of the Practice including day-to-day operations and strategic development activities.

  • Steering Committee The Project Manager shall set up a Steering Committee for the Project, consisting of representatives from the Department, the Contractor, and any other key organisations whom the project will impact on, to be agreed between the parties. The function of the Steering Committee shall be to review the scope and direction of the Project against its aims and objectives, monitor progress and efficiency, and assess, manage and review expected impact and use of the findings from the Project. The Committee shall meet at times and dates agreed by the parties, or in the absence of agreement, specified by the Department. The Contractor’s representatives on the Steering Committee shall report their views on the progress of the Project to the Steering Committee in writing if requested by the Department. The Contractor’s representatives on the Steering Committee shall attend all meetings of the Steering Committee unless otherwise agreed by the Department.

  • Development Committee As soon as practicable, the Parties will establish a joint development committee, comprised of at least one (1) and up to two (2) representatives of Omega and at least one (1) and up to two (2) representatives of Acuitas (the “JDC”). One such representative from each Party will be such Party’s Workplan Leader. Each Party may replace its Workplan Leader and other JDC representatives at any time upon written notice to the other Party, provided, however, that each Party shall use reasonable efforts to ensure continuity on the JDC. With the consent of the other Party (which will not be unreasonably withheld, conditioned or delayed), each Party may invite non-voting employees and consultants to attend JDC meetings as necessary, subject to consultant’s agreement to be bound to the same extent as a permitted subcontractor under Section 3.1(i).

  • Research Committee 2.2.1 Establishment and Functions of RC. ---------------------------------

  • Project Leaders Within [**] Business Days after the Effective Date, each Party will appoint (and provide written notice to the other Party of the identity of) a senior representative having a general understanding of biopharmaceutical discovery and development issues to act as its project leader under this Agreement (each, a “Project Leader”). The Project Leaders will serve as the contact point between the Parties with respect to the Research Program, and will be primarily responsible for: (a) facilitating the flow of information and otherwise promoting communication, coordination of the day-to-day work and collaboration between the Parties; (b) providing single point communication for seeking consensus internally within the respective Party’s organization; and (c) raising cross-Party or cross-functional disputes in a timely manner. The Project Leaders shall conduct regular telephone conferences as deemed necessary or appropriate, to exchange informal information regarding the progress of the Research Program. Each Party may change its designated Project Leader from time to time upon prior written notice to the other Party. Each Project Leader may designate a substitute to temporarily perform the functions of that Project Leader by prior written notice to the other Party.

  • Joint Development Committee The Parties shall form a joint development committee (the “Joint Development Committee” or “JDC”), made up of an equal number of representatives of Merck and BioLineRx, which shall have responsibility of coordinating all regulatory and other activities under, and pursuant to, this Agreement. Each Party shall designate a project manager (the “Project Manager”) who shall be responsible for implementing and coordinating activities, and facilitating the exchange of information between the Parties, with respect to the Study. Other JDC members will be agreed by both Parties. The JDC shall meet as soon as practicable after the Effective Date and then no less than twice yearly, and more often as reasonably considered necessary at the request of either Party, to provide an update on the progress of the Study. The JDC may meet in person or by means of teleconference, Internet conference, videoconference or other similar communications equipment. Prior to any such meeting, the BioLineRx Project Manager shall provide an update in writing to the Merck Project Manager, which update shall contain information about the overall progress of the Study, recruitment status, interim analysis (if results available), final analysis and other information relevant to the conduct of the Study. In addition to a Project Manager, each Party shall designate an alliance manager (the “Alliance Manager”), who shall endeavor to ensure clear and responsive communication between the Parties and the effective exchange of information, and shall serve as the primary point of contact for any issues arising under this Agreement. The Alliance Managers shall have the right to attend all JDC meetings and may bring to the attention of the JDC any matters or issues either of them reasonably believes should be discussed, and shall have such other responsibilities as the Parties may mutually agree in writing. In the event that an issue arises and the Alliance Managers cannot or do not, after good faith efforts, reach agreement on such issue, the issue shall be elevated to the Head of Clinical Oncology for Merck and the Vice President of Medical Affairs or Business Development for BioLineRx.

  • Joint Steering Committee [***] following the Effective Date [***], a joint steering committee (the “JSC”) will be established by the Parties to provide oversight and to facilitate information sharing between the Parties with respect to the activities under this Agreement.

  • Working Groups From time to time, a Joint Committee may establish and delegate duties to sub-committees or directed teams (each, a “Working Group”) on an “as-needed” basis to oversee particular projects or activities (e.g., joint project team, joint finance group, or joint intellectual property group). Each such Working Group shall be constituted and shall operate as the Joint Committee determines; provided, that each Working Group shall have equal representation from each Party, unless otherwise mutually agreed. Working Groups may be established on an ad hoc basis for purposes of a specific project or on such other basis as the Joint Committee may determine. Each Working Group and its activities shall be subject to the oversight, review and approval of, and shall report to, the Joint Committee that formed said Working Group. In no event shall the authority of the Working Group exceed that specified for the Joint Committee that formed the Working Group. All decisions of a Working Group shall be by unanimous agreement. Any disagreement between the designees of AbbVie and Ablynx on a Working Group shall be referred to the Joint Committee that formed the Working Group for resolution.

  • Joint Project Team As soon as possible after the Effective Date, the Parties shall establish a joint project team (the “JPT”) which shall be initially responsible for the day-to-day operations of the Initial Target Program. The JPT shall also be responsible for the day-to-day operations of all other Collaboration Programs when they become ***Portions of this page have been omitted pursuant to a request for Confidential Treatment and filed separately with the Commission. effective; provided, that if multiple JPTs are needed due to different Targets or disease areas, then the Parties may establish separate JPTs for different Collaboration Programs. The JPT shall be comprised of representatives from each of GSK and Adaptimmune with the appropriate scientific expertise with respect to the conduct of the Development Plans (and such representatives may vary depending on the relevant Project Phase) and shall meet on a monthly basis (or more or less frequently as agreed by the Parties) at Adaptimmune’s facilities, GSK’s facilities or via teleconference at such times as may be agreed by the Parties during the term of the applicable Collaboration Program. The JPT will report to the JSC and will be responsible for the day-to-day management of the conduct of the Development Plans including any non-material changes to the Development Plans, overseeing the conduct of experiments and reviewing data resulting from such experiments as set forth in the Development Plans, proposing amendments to the Development Plans, proposing new Development Plans to the JSC for new Collaboration Programs for JSC approval, discussing potential Lead Candidates and Development Candidates for proposal to the JSC. All decisions of the JPT on matters for which it has responsibility shall be made unanimously. In the event that the JPT is unable to reach a unanimous decision within ten (10) Business Days after it has met and attempted to reach such decision, then either Party may, by written notice to the other, have such issue submitted to the JSC for resolution in accordance with Section 4.5. Each Party will bear all expenses it incurs in regard to participating in all meetings of the JPT, including all travel and living expenses. Each JPT shall automatically cease to exist on completion of the relevant Collaboration Programs that it supports and exercise or expiry of all Collaboration Program Options applicable to such Collaboration Programs.

Time is Money Join Law Insider Premium to draft better contracts faster.